Who
George de Urioste
Director
Company insider
Files Form 4 as: Director, Heartbeam; Director, Blaize Holdings; Director, Saba Software; Acting Chief Operating Officer, Marvell Technology Group; COO & CFO, Chordiant Software.
In numbers
- Trades disclosed
- 58
- Buys
- 0
- Sells
- 25
- Bought
- $0
- Sold
- $1.1M
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 1 Feb 2006
- Last trade
- 2 Oct 2026
- Last filed
- 9 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 9 Oct 2026 | BEAT Heartbeamoption or derivative · Medical Devices | SEC FORM 4 Code A | —93,750 at $0.00 | filing |
| 2 Oct 2026filed 9 Oct 2026 | BEAT Heartbeamoption or derivative · Medical Devices | SEC FORM 4 Code A | —93,750 at $0.00 | filing |
| 9 Feb 2026filed 23 Mar 2026 | BEAT Heartbeamoption or derivative · Medical Devices | SEC FORM 4 Code A | —51,724 at $0.00 | filing |
| 9 Feb 2026filed 23 Mar 2026 | BEAT Heartbeamoption or derivative · Medical Devices | SEC FORM 4 Code A | —51,724 at $0.00 | filing |
| 18 Dec 2025filed 19 Dec 2025 | BEAT HeartbeamMedical Devices | SEC FORM 4 Sold | $94K33,185 at $2.83 | filing |
| 17 Dec 2025filed 19 Dec 2025 | BEAT HeartbeamMedical Devices | SEC FORM 4 Sold | $88K23,961 at $3.68 | filing |
| 3 Dec 2025filed 5 Dec 2025 | BZAI Blaize HoldingsSemiconductors | SEC FORM 4 Code A | —75,258 at $0.00 | filing |
| 28 Jun 2025filed 2 Jul 2025 | BZAI Blaize HoldingsSemiconductors | SEC FORM 4 Code A | —94,361 at $0.00 | filing |
| 6 Sep 2024filed 11 Sep 2024 | BEAT HeartbeamMedical Devices | SEC FORM 4 Sold | $3,9171,674 at $2.34 | filing |
| 30 Aug 2024filed 4 Sep 2024 | BEAT HeartbeamMedical Devices | SEC FORM 4 Sold | $13K5,500 at $2.31 | filing |
| 27 Aug 2024filed 29 Aug 2024 | BEAT HeartbeamMedical Devices | SEC FORM 4 Sold | $4,9582,194 at $2.26 | filing |
| 26 Aug 2024filed 27 Aug 2024 | BEAT HeartbeamMedical Devices | SEC FORM 4 Sold | $714300 at $2.38 | filing |
| 23 Aug 2024filed 27 Aug 2024 | BEAT HeartbeamMedical Devices | SEC FORM 4 Sold | $5,7502,500 at $2.30 | filing |
| 12 Jun 2024filed 20 Jun 2024 | BEAT HeartbeamMedical Devices | SEC FORM 4 Code A | —33,185 at $0.00 | filing |
| 29 Sep 2023filed 3 Oct 2023 | BEAT HeartbeamMedical Devices | SEC FORM 4 Sold | $11K5,500 at $2.06 | filing |
| 28 Sep 2023filed 29 Sep 2023 | BEAT HeartbeamMedical Devices | SEC FORM 4 Sold | $16K8,000 at $2.04 | filing |
| 27 Sep 2023filed 29 Sep 2023 | BEAT HeartbeamMedical Devices | SEC FORM 4 Sold | $3,8701,834 at $2.11 | filing |
| 26 Sep 2023filed 27 Sep 2023 | BEAT HeartbeamMedical Devices | SEC FORM 4 Sold | $10K5,000 at $2.09 | filing |
| 22 Sep 2023filed 27 Sep 2023 | BEAT HeartbeamMedical Devices | SEC FORM 4 Sold | $5,2892,393 at $2.21 | filing |
| 21 Sep 2023filed 22 Sep 2023 | BEAT HeartbeamMedical Devices | SEC FORM 4 Sold | $241100 at $2.41 | filing |
News
HeartBeam (NASDAQ:BEAT) Upgraded at Wall Street ZenBEAT · themarketsdaily.com · 13 Oct 2026
0 headlines in the last 90 days name George de Urioste; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.
Sectors
Related people
Nobody else traded the same names lately.